Skip to main content

VivoSim Labs, INC.

VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001497253

In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding VivoSim Labs, INC. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of VIVS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders441430
Shares2.01M4982.01M+4.69K (+0.2%)
Value$3.43M$842$4.07M+$643.2K (+18.7%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held VivoSim Labs, INC. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to VIVS in Q3 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC24,258$50.0K0.00%
Virtu Financial LLC14,703$30.0K0.00%
Dimensional Fund Advisors LP11,040$23.0K0.00%
Householder Group Estate & Retirement Specialist, LLC1$00.00%
Activest Wealth Management125$00.00%

Sold out (5)

Institutions that held VivoSim Labs, INC. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of VIVS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Accel Wealth Management9,000$24.0K
Simplex Trading, LLC594$1.00K
Captrust Financial Advisors657$1.00K
Toronto Dominion Bank44$0
Northwestern Mutual Wealth Management Co8$0

Not filed for Q3 2022 yet (1)

Institutions that held VivoSim Labs, INC. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VIVS in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Quintet Private Bank (Europe) S.A.498$842